In neuroblasts with enhancer hijacking, the super-enhancer on the intact allele drives HAND2 expression, while the HAND2 super-enhancer on the translocated allele continues to drive expression of MYC or MYCN as the retino-sympathetic CRC is attempting to form during ATRA treatment. The gene discussed is HAND2; the disease is colorectal carcinoma.